Institution address

Folkhälsan Inst of Genetics, Folkhälsan Research Center; Haartmaninkatu 8, Biomedicum 1; P.O. Box 63, FI-00014; Univ of Helsinki, Finland

Helsinki Univ Central Hospital, Dept of Medicine, Division of Nephrology; PL 263, FI-00029; Helsinki, Finland

Haluatko osallistua ravintotutkimukseen?
Katso lisätiedot.

Castelli Pedroli Prize awarded to Per-Henrik Groop

The principal investigator of the Finnish Diabetic Nephropathy Study, Associate Professor Per-Henrik Groop, was awarded the Castelli Pedroli Prize for achievements in the study of diabetic complications. The official seremony took place in the 2009 Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria, where Prof Groop also gave the 24th Camillo Golgi lecture.

The FinnDiane Group congratulates Prof Groop, or "Perra", for this important international recognition and we are enthusiastic to continue together on our journey towards new scientific discoveries and new remedies for the affected patients.

The FinnDiane Study Group

Latest from PubMed

In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2010 Jul 28;

DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes. Diabetologia. 2010 May 21;

Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia. 2010 Apr 16;

Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes. J Intern Med. 2010 Mar;267(3):278-86

Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 2010 Feb 25;

Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy. Steroids. 2010 Jan 24;

Health-related quality of life in patients with type 1diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant. 2009 Dec 27;

Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care. 2009 Sep;32(9):1689-93

Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia. 2009 Nov 4;

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia. 2009 Oct 10;

Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study). Cardiovasc Diabetol. 2009 Oct 6;8(1):54

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009 Aug 3;

Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial. Diabetes. 2009 Aug;58(8):1914-20

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009 Jul;58(7):1651-8

Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy. Diabetes. 2009 Jul;58(7):1710-4

Early autonomic dysfunction in type 1 diabetes: a reversible disorder? Diabetologia. 2009 Jun;52(6):1164-72

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2009 May;32(5):950-2

Effect of parental type 2 diabetes on offspring with type 1 diabetes. Diabetes Care. 2009 Jan;32(1):63-8

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes. 2008 Sep;57(9):2480-7

Heritability of proliferative diabetic retinopathy. Diabetes. 2008 Aug;57(8):2176-80

View fewer items.

Updated 2010-01-05 by vpmakine.